Clinical Trials for Anticoagulant-induced Bleeding

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

NCT ID: NCT04263038

**Summary of the SAFE-SSPE Clinical Trial** The SAFE-SSPE trial is investigating whether low-risk patients with a specific type of blood clot in the lungs, known as isolated subsegmental pulmonary...

Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study

NCT ID: NCT06887270

The VENOCAT trial aims to find the best way to manage a type of blood thinner called direct oral anticoagulants (DOACs) for cancer patients who need a central venous catheter (CVC). This is a thin ...

LMWH Vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

NCT ID: NCT03244020

Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement

NCT ID: NCT06627933

This clinical trial is looking at how to improve care for patients with heart problems who are undergoing surgery to replace joints in their legs. Specifically, the study aims to understand how oft...

Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients

NCT ID: NCT06194617

This clinical trial is studying the use of a medication called rivaroxaban in older Chinese patients who have experienced a condition known as venous thromboembolism, which includes serious issues ...

Anticoagulant-associated Intracranial Hemorrhage

NCT ID: NCT06168838

This clinical trial is investigating the risk of bleeding in the brain, known as intracranial hemorrhage, that may be associated with different blood-thinning medications, particularly newer ones c...

Anticoagulation After GI Bleeding Pilot Study and Registry

NCT ID: NCT05290857

The PANTHER-GI Pilot Study is a research trial that aims to understand how safely patients can start taking a specific type of blood thinner, known as direct oral anticoagulants (DOACs), after expe...